Vurdering af reguleringsmæssige behov - liste

Vurdering af reguleringsmæssige behov - liste

The assessment of regulatory needs list includes substances for which an assessment either is under development or has been completed. 

For each substance, the table shows the assessing authority (submitter), the concern, the status and the suggested follow-up action, and the date of the latest update to the list entry.

Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.

Regulatory Management Option Analysis (RMOA) are assessments of regulatory needs. Publication of RMOA was initiated in February 2013 with the start of the implementation of the SVHC Roadmap. In 2019, authorities and in particular ECHA have moved to address more groups of substances.

The responsibility for the content of an assessment of regulatory needs rests with the authority that developed it. It is possible that other authorities do not have the same view and may develop a further assessment of regulatory needs for the same (group of) substances. Assessment of regulatory needs and their conclusions are compiled based on available information and may change in light of new information or further assessment.  

Last updated 16 maj 2024. Database contains 5055 unique substances/entries.
Filter the list
Foreseen regulatory need:
Date of intention:
Date of assessment:
Latest update:

The List does not contain any Substances.
 
282-104-8
84100-23-2
ECHA
Under development
CCH
Other action
08-jul.-2021
Details
205-426-2
140-66-9
ECHA
Concluded
Other action
19-nov.-2021
Details
201-250-5
80-09-1
ECHA
Under development
Other action
Other action
16-dec.-2021
Details
210-658-2
620-92-8
ECHA
Under development
Other action
16-dec.-2021
Details
201-245-8
80-05-7
ECHA
Under development
Other action
16-dec.-2021
Details
216-036-7
1478-61-1
ECHA
Under development
Other action
Other action
16-dec.-2021
Details
201-025-1
77-40-7
ECHA
Under development
Other action
16-dec.-2021
Details
215-925-7
1453-58-3
ECHA
Under development
CCH
Further assessment
Other action
30-apr.-2020
Details
264-727-7
64194-22-5
ECHA
Under development
Other action
08-jul.-2021
Details
203-653-1
109-17-1
ECHA
Under development
Other action
08-jul.-2021
Details
231-927-0
7779-31-9
ECHA
Under development
CCH
Other action
08-jul.-2021
Details
289-200-9
86178-38-3
ECHA
Under development
Other action
08-jul.-2021
Details
700-319-1
117646-83-0
ECHA
Under development
CCH
Other action
08-jul.-2021
Details
201-807-2
88-18-6
ECHA
Concluded
Other action
19-nov.-2021
Details
810-760-2
149855-64-1
ECHA
Under development
Other action
08-jul.-2021
Details
629-850-6
1245638-61-2
ECHA
Under development
Other action
08-jul.-2021
Details
800-838-4
1384855-91-7
ECHA
Under development
CCH
Other action
08-jul.-2021
Details
810-816-6
1473386-36-5
ECHA
Under development
Other action
08-jul.-2021
Details
810-817-1
1473386-29-6
ECHA
Under development
Other action
08-jul.-2021
Details
292-081-6
90530-40-8
ECHA
Under development
Other action
08-jul.-2021
Details
292-122-8
90552-02-6
ECHA
Under development
Other action
08-jul.-2021
Details
212-782-2
868-77-9
ECHA
Under development
CLH
Other action
08-jul.-2021
Details
212-454-9
818-61-1
ECHA
Under development
Other action
08-jul.-2021
Details
605-717-8
174333-80-3
ECHA
Under development
Other action
03-mar.-2022
Details
941-880-4
-
ECHA
Under development
Other action
03-mar.-2022
Details
203-080-7
103-11-7
ECHA
Under development
CLH
Other action
08-jul.-2021
Details
1 - 2.5 moles ethoxylated
500-156-4
62722-22-9
ECHA
Under development
Other action
08-jul.-2021
Details
239-701-3
15625-89-5
ECHA
Under development
Other action
08-jul.-2021
Details
500-086-4
35238-34-7
ECHA
Under development
Other action
16-dec.-2021
Details
931-252-8
-
ECHA
Under development
Other action
16-dec.-2021
Details
908-912-9
1333-16-0
ECHA
Under development
Other action
16-dec.-2021
Details
230-813-8
7328-22-5
ECHA
Under development
Other action
08-jul.-2021
Details
204-884-0
128-39-2
ECHA
Concluded
Other action
19-nov.-2021
Details
943-503-9
-
ECHA
Under development
Other action
16-dec.-2021
Details
202-532-0
96-76-4
ECHA
Concluded
Other action
19-nov.-2021
Details
211-989-5
732-26-3
ECHA
Concluded
Other action
19-nov.-2021
Details
203-441-9
106-91-2
ECHA
Under development
CCH
Other action
01-jul.-2021
Details
227-642-6
5919-74-4
ECHA
Under development
CCH
Other action
08-jul.-2021
Details
202-480-9
96-13-9
ECHA
Under development
Other action
04-okt.-2021
Details
253-057-0
36483-57-5
ECHA
Under development
Other action
04-okt.-2021
Details
221-967-7
3296-90-0
ECHA
Under development
Other action
04-okt.-2021
Details
AP-5
401-720-1
6807-17-6
ECHA
Under development
Other action
16-dec.-2021
Details
203-652-6
109-16-0
ECHA
Under development
Other action
08-jul.-2021
Details
202-268-6
93-69-6
ECHA
Under development
CCH
Other action
27-sep.-2021
Details
214-711-0
1189-08-8
ECHA
Under development
Other action
08-jul.-2021
Details
627-083-1
244235-47-0
ECHA
Under development
Other action
03-mar.-2022
Details
204-661-8
123-91-1
ECHA
Under development
Other action
07-dec.-2021
Details
213-979-6
1070-70-8
ECHA
Under development
CCH
Other action
08-jul.-2021
Details
276-900-4
72829-09-5
ECHA
Under development
CCH
Other action
08-jul.-2021
Details
235-922-4
13048-34-5
ECHA
Under development
CCH
Other action
08-jul.-2021
Details
229-745-1
6701-13-9
ECHA
Under development
CCH
Other action
08-jul.-2021
Details
300-723-4
127823-21-6
ECHA
Under development
Other action
08-jul.-2021
Details
255-901-3
42594-17-2
ECHA
Under development
CCH
Other action
08-jul.-2021
Details
256-062-6
43048-08-4
ECHA
Under development
CCH
Other action
08-jul.-2021
Details
256-032-2
42978-66-5
ECHA
Under development
Other action
08-jul.-2021
Details
204-112-2
115-86-6
France
Endocrine disruption
Skin sensitiser
Concluded
Other
10-sep.-2019
Details
202-924-1
101-20-2
France
Endocrine disruption
Concluded
Other
09-aug.-2018
Details
203-625-9
108-88-3
Netherlands
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Other
13-jul.-2020
Details
260-830-6
57583-54-7
France
Endocrine disruption
Concluded
Other
10-aug.-2018
Details
238-877-9
14807-96-6
Netherlands
Carcinogenic
STOT RE
Concluded
CLH
Other
10-dec.-2021
Details
215-185-5
1310-73-2
Sweden
Other human toxicity
Concluded
Other
08-apr.-2015
Details
215-181-3
1310-58-3
Sweden
Other human toxicity
Concluded
Other
08-apr.-2015
Details
231-106-7
7439-97-6
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Other
23-sep.-2014
Details
610-589-1
50926-11-9
Netherlands
Other environmental toxicity
Other human toxicity
Toxic for reproduction
Concluded
Other
13-okt.-2018
Details
204-260-8
118-56-9
France
Endocrine disruption
Respiratory sensitiser
Skin sensitiser
Concluded
Other
27-mar.-2019
Details
258-649-2
53585-53-8
Finland
Bioaccumulation
Other environmental toxicity
Persistence
Concluded
Other
24-feb.-2020
Details
231-150-7
7440-41-7
Germany
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Other
19-dec.-2016
Details
232-565-6
9000-90-2
United Kingdom
Respiratory sensitiser
Skin sensitiser
Concluded
Other
17-jul.-2018
Details
250-863-4
31906-04-4
Sweden
Skin sensitiser
Concluded
Other
05-jun.-2015
Details
690-137-8
5436-43-1
France
Endocrine disruption
Concluded
Other
30-jan.-2019
Details
214-946-9
1222-05-5
France
Endocrine disruption
Concluded
Other
22-jan.-2020
Details
400-370-7
6196-98-1
Finland
Bioaccumulation
Other environmental toxicity
Persistence
Concluded
Other
24-feb.-2020
Details
203-293-5
105-38-4
Sweden
Carcinogenic
Mutagenic
Concluded
None
11-dec.-2020
Details
203-545-4
108-05-4
Sweden
Carcinogenic
Mutagenic
Concluded
None
11-dec.-2020
Details
225-768-6
5064-31-3
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
None
23-sep.-2014
Details
234-829-6
12035-72-2
Hungary
Carcinogenic
Mutagenic
Skin sensitiser
Toxic for reproduction
Concluded
None
12-maj-2017
Details
201-067-0
77-90-7
France
Endocrine disruption
Concluded
None
07-nov.-2016
Details
203-625-9
108-88-3
Denmark
Mutagenic
Toxic for reproduction
Widespread use
Concluded
None
12-jan.-2017
Details
202-830-0
100-21-0
France
Endocrine disruption
Concluded
None
07-mar.-2017
Details
911-915-8
-
Ireland
Bioaccumulation
Carcinogenic
Endocrine disruption
Mutagenic
Persistence
Respiratory sensitiser
STOT RE
Skin sensitiser
Toxic for reproduction
Concluded
None
05-jul.-2023
Details
202-051-6
91-22-5
Ireland
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
None
10-jul.-2015
Details
272-234-3
68784-26-9
Sweden
Toxic for reproduction
Concluded
None
28-nov.-2018
Details
272-233-8
68784-25-8
Sweden
Mutagenic
Toxic for reproduction
Concluded
None
28-nov.-2018
Details
272-486-4
68855-45-8
Sweden
Toxic for reproduction
Concluded
None
28-nov.-2018
Details
229-891-6
6818-37-7
Ireland
Bioaccumulation
Carcinogenic
Endocrine disruption
Mutagenic
Persistence
Respiratory sensitiser
STOT RE
Skin sensitiser
Toxic for reproduction
Concluded
None
05-jul.-2023
Details
227-534-9
5873-54-1
Denmark
Respiratory sensitiser
Skin sensitiser
Toxic for reproduction
Concluded
None
23-sep.-2014
Details
240-841-2
16812-54-7
Germany
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
None
12-maj-2017
Details
629-719-3
1219010-04-4
Sweden
STOT RE
Concluded
None
16-apr.-2019
Details
679-769-5
2675-94-7
Sweden
Carcinogenic
Mutagenic
Concluded
None
25-aug.-2021
Details
215-204-7
1313-27-5
Denmark
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
None
01-dec.-2020
Details
247-714-0
26447-40-5
Denmark
Carcinogenic
Mutagenic
Skin sensitiser
Toxic for reproduction
Concluded
None
23-sep.-2014
Details
200-659-6
67-56-1
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
None
08-jul.-2016
Details
231-106-7
7439-97-6
Sweden
Other human toxicity
STOT RE
Toxic for reproduction
Concluded
None
09-feb.-2018
Details
203-615-4
108-78-1
France
Endocrine disruption
Concluded
None
29-apr.-2024
Details
232-089-9
7785-87-7
Denmark
Carcinogenic
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
None
12-jan.-2017
Details
247-722-4
26471-62-5
Denmark
Carcinogenic
Mutagenic
Skin sensitiser
Toxic for reproduction
Concluded
None
23-sep.-2014
Details
200-579-1
64-18-6
Bulgaria
Bioaccumulation
Endocrine disruption
Other human toxicity
Persistence
Concluded
None
05-jul.-2017
Details
629-757-0
1224966-15-7
Netherlands
Other environmental toxicity
Other human toxicity
Concluded
None
05-jul.-2017
Details
291-275-8
90367-27-4
Ireland
Bioaccumulation
Carcinogenic
Endocrine disruption
Mutagenic
Persistence
Respiratory sensitiser
STOT RE
Skin sensitiser
Toxic for reproduction
Concluded
None
05-jul.-2023
Details
291-269-5
90367-21-8
Ireland
Bioaccumulation
Carcinogenic
Endocrine disruption
Mutagenic
Persistence
Respiratory sensitiser
STOT RE
Skin sensitiser
Toxic for reproduction
Concluded
None
05-jul.-2023
Details

Export search results to: